Log In
Print
BCIQ
Print
Print this Print this
 

Oncotype DX breast cancer assay

  Manage Alerts
Collapse Summary General Information
Company Genomic Health Inc.
DescriptionDiagnostic assay that analyzes the expression of 21 genes to generate a Recurrence Score (RS) to quantify magnitude of chemotherapy benefit and likelihood of recurrence
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Latest Stage of DevelopmentMarketed
IndicationCancer, Diagnostic
Partner

NewBridge Pharmaceuticals Ltd.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today